MYD88 and Sepsis: Key findings: MAF reduces LPS‐induced inflammatory reaction in vitro and in vivo; MAF exerts its anti‐inflammatory effect by inhibiting the TLR4/MyD88/NF‐κB pathway; MAF corrects intestinal flora imbalance during early stage of sepsis to some degree.